Aaron Weitzman
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Chronic Myeloid Leukemia Treatments 6
-
- Prostate Cancer Treatment and Research 7
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Francis Joseph Giles (6 shared papers)Hagop M. Kantarjian (5 shared papers)Yaping Shou (3 shared papers)Philipp le Coutre (5 shared papers)Andreas Hochhaus (5 shared papers)Md Ariful Haque (3 shared papers)Kapil N. Bhalla (3 shared papers)Norbert Gattermann (3 shared papers)
- Journals
- Blood (7 papers)Journal of Clinical Oncology (3 papers)Annals of Oncology (2 papers)European Urology (2 papers)Value in Health (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Aaron Weitzman
24 papers receiving 1.7k citations
Aaron Weitzman's Hit Papers
Peers
Comparison fields: 5 of 79
- Hematology 588
- Pulmonary and Respiratory Medicine 569
- Oncology 217
- Pharmacology 88
- Pathology and Forensic Medicine 70
Countries citing papers authored by Aaron Weitzman
This map shows the geographic impact of Aaron Weitzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Weitzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Weitzman more than expected).
Fields of papers citing papers by Aaron Weitzman
This network shows the impact of papers produced by Aaron Weitzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Weitzman. The network helps show where Aaron Weitzman may publish in the future.
Co-authors
The 25 scholars most cited alongside Aaron Weitzman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance Hit paper breakdown → | 2007 | 604 |
| 2 | Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial Hit paper breakdown → | 2012 | 377 |
| 3 | 2016 | 213 | |
| 4 | 2007 | 105 | |
| 5 | Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer. | 1999 | 81 |
| 6 | 2017 | 57 | |
| 7 | 2000 | 50 | |
| 8 | 2018 | 48 | |
| 9 | 2019 | 48 | |
| 10 | 2014 | 36 | |
| 11 | 2005 | 27 | |
| 12 | 2006 | 26 | |
| 13 | 2006 | 19 | |
| 14 | 2004 | 18 | |
| 15 | 2006 | 18 | |
| 16 | 2006 | 18 | |
| 17 | 2008 | 13 | |
| 18 | 2006 | 10 | |
| 19 | 2006 | 7 | |
| 20 | 2006 | 5 |
About Aaron Weitzman
Aaron Weitzman is a scholar working on Hematology, Pulmonary and Respiratory Medicine, Oncology, Anesthesiology and Pain Medicine and Pharmacology, having authored 24 papers that have together received 1.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Lung Cancer Treatments and Mutations (2 papers), Inflammatory mediators and NSAID effects (2 papers), Cancer survivorship and care (2 papers), Pain Management and Opioid Use (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Hematology (588 citations), Pulmonary and Respiratory Medicine (569 citations), Oncology (217 citations), Pharmacology (88 citations) and Pathology and Forensic Medicine (70 citations). Aaron Weitzman has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Francis Joseph Giles, Hagop M. Kantarjian, Yaping Shou, Philipp le Coutre, Andreas Hochhaus, Md Ariful Haque, Kapil N. Bhalla, Norbert Gattermann, Giuliana Alimena and Francisco Cervantes. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, European Urology and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.